SciDev Ltd (ASX: SDV) faced a challenging 1H FY26, reporting a decline in revenue to AU$47.9 million, down from AU$49.9 million in the previous year. The company attributed the drop primarily to two factors: a significant reduction in sales of its premium product, xSlik®, following a schedule change by a key customer in the US, and escalating costs in its international Water Technologies business. Despite these challenges, SciDev's Process Chemistry segment showed strong growth, achieving a 16% increase in revenue, reaching AU$14.5 million, supported by major tunneling contracts.
Additionally, the company's domestic Water Technologies business returned to profitability, with an underlying EBITDA of AU$0.2 million, reflecting strategic shifts to higher-margin services. Looking ahead, SciDev has revised its full-year revenue guidance to AU$100-110 million, with expectations of stronger performance in 2H FY26. The company has adopted measures to reduce expenses and expects improved EBITDA margins in the latter half of the year.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au
x
Daily Dose of Buy, Sell & Hold recommendations before the market opens.
Start Your 7 Days Free Trial Now!
We use cookies to help us improve, promote, and protect our services.
By continuing to use this site, we assume you consent to this.
Read our
Privacy Policy
and
Terms & Conditions
SciDev Ltd 1H FY26 Financial Performance
SciDev Ltd (ASX: SDV) faced a challenging 1H FY26, reporting a decline in revenue to AU$47.9 million, down from AU$49.9 million in the previous year. The company attributed the drop primarily to two factors: a significant reduction in sales of its premium product, xSlik®, following a schedule change by a key customer in the US, and escalating costs in its international Water Technologies business. Despite these challenges, SciDev's Process Chemistry segment showed strong growth, achieving a 16% increase in revenue, reaching AU$14.5 million, supported by major tunneling contracts.
Additionally, the company's domestic Water Technologies business returned to profitability, with an underlying EBITDA of AU$0.2 million, reflecting strategic shifts to higher-margin services. Looking ahead, SciDev has revised its full-year revenue guidance to AU$100-110 million, with expectations of stronger performance in 2H FY26. The company has adopted measures to reduce expenses and expects improved EBITDA margins in the latter half of the year.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au